Company Analysis

Envoy Medical, Inc. (COCH)

Nasdaq: COCH · Orthopedic, Prosthetic & Surgical Appliances & Supplies · White Bear Lake, MN · filing with the SEC since 2021
Grade2.6
◀ Past 2.0● Present 1.4▶ Future 4.9
2 est.

Filings

252 filings since 2017 beside 78 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Aug 31, 2026.

Filings a yearinsider forms included
251690726859
202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 10 times in the last 36 months, the newest Aug 27, 2026.Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest May 22, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 31, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Dec 19, 2023.SEC letters: 9 in the last 36 months, the newest Feb 9, 2026.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms 78

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 27, 2026 8-K items 3.03, 5.03, 7.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Oct 23, 2026
Oct 16, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Oct 12, 2026
Oct 7, 2026 8-K items 8.01, 9.01 Other event · Current report Oct 6, 2026
Sep 14, 2026 SCHEDULE 13G/A Large holder update, amended
Sep 2, 2026 DEFA14A Extra proxy material
Aug 31, 2026 DEF 14A Proxy statement Oct 12, 2026
Aug 27, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Aug 24, 2026
Aug 19, 2026 PRE 14A Preliminary proxy statement
Aug 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Jun 30, 2026 8-K items 1.02, 9.01 Major agreement ended · Current report Jun 24, 2026
Jun 25, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Jun 19, 2026
Jun 16, 2026 EFFECT Registration effective
Jun 12, 2026 POS AM Registration amended after taking effect
Jun 12, 2026 S-8 Employee stock plan registration
May 22, 2026 8-K item 3.01 Listing warning from its exchange · Current report May 19, 2026
May 18, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report May 12, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 14, 2026 SCHEDULE 13G Large holder notice
May 11, 2026 SCHEDULE 13G/A Large holder update, amended
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 21, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Apr 15, 2026
Apr 13, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 2, 2026 DEFA14A Extra proxy material
Apr 2, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 2, 2026 DEF 14A Proxy statement May 12, 2026
Mar 31, 2026 8-K items 4.01, 9.01 Auditor change · Current report Mar 25, 2026
Mar 27, 2026 8-K items 2.02, 9.01 Results released · Current report Mar 23, 2026
Mar 23, 2026 PRE 14A Preliminary proxy statement
Mar 23, 2026 10-K Annual report Dec 31, 2025
Feb 27, 2026 8-K items 3.01, 8.01, 9.01 Listing warning from its exchange; Other event · Current report Feb 23, 2026
Feb 17, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 13, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Feb 11, 2026
Feb 12, 2026 424B4 Offering prospectus
Feb 12, 2026 424B4 Offering prospectus
Feb 11, 2026 EFFECT Registration effective
Feb 11, 2026 SCHEDULE 13G Large holder notice
40 of 252 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton COCH · research, not advice